Abstract Library

#1861 Surgical Strategies and Selection Criteria for Patients with Liver Metastasis from Neuroendocrine Tumors: Personal Experience.

Introduction: The role of surgical treatment of liver metastasis from neuroendocrine neoplasm(NET) is still a debated issue,and the management of these patients is entrusted to the practical experience of single centers.The main problem is that there are not available randomized trials comparing surgical resection to unthreated patients or other liver directed therapy.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Pauletti B

Authors: Massani M, Pauletti B, Bonariol R, Bassi N,

Keywords: NET, liver metastasis, surgery,

#1396 3-Drugs Chemotherapy Regimen for G3 PanNENs with Ki67 below 55%: Single Institution Experience

Introduction: To date no standard regimen of chemotherapy (CTH) is universally approved for advanced pancreatic neuroendocrine neoplasms (PanNENs) with Ki67<55% and no predictive selection criteria is available.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Grego E

Authors: Grego E, Cingarlini S, Ortolani S, Crosara S, De Robertis R,

Keywords: 3-drugs chemotherapy regimen, pancreatic nets, ki-67% <55%,

#620 Multicenter Retrospective Analysis of Systemic Chemotherapy for Advanced Poorly Differentiated Neuroendocrine Carcinoma of Digestive System

Introduction: No standard chemotherapy is established for advanced poorly differentiated neuroendocrine carcinoma (PDNEC) originating from the gastrointestinal tract (GI) or the hepato-biliary-pancreatic system (HBP).

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Tomohiro Y

Authors: Yamaguchi T, Machida N, Kasuga A, Takahashi H, Sudo K,

Keywords: poorly-differentiated, PDNEC, irinotecan, etoposide, gastrointestinal,

#530 Liver Transplantation for Metastatic Neuroendocrine Tumor: A Case Series and Proposed Selection Criteria

Introduction: Liver transplantation (LT) for neuroendocrine tumor (NET) metastases is associated with a high risk of tumor recurrence. Patient selection is the key to future success and its increased utilization.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Chan G, Kocha W, Reid R, Taqi A, Wall W,

Keywords: liver transplantation, neuroendocrine tumor, metastases,

#203 Liver and Liver-Pancreastransplantation in the Two-stage Treatment of Liver Metastasized Neuroendocrine Tumors of the Pancreas: About Three Cases

Introduction: Although liver transplantation is a valid option in the treatment of metastasized neuroendocrine tumors, it is not promoted because of a donor organ shortage and disappointing results in older series.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Roeyen G, Chapelle T, De Greef K, Francque S, Michielsen P,

Keywords: livertransplantation, neuroendocrine tumor, selection criteria,